5 Best Medical Stocks to Invest In

3. Pfizer Inc. (NYSE: PFE)

Market Cap: $218 billion
Number of Hedge Fund Holders: 65 

Pfizer Inc. (NYSE: PFE) is a New York-based biopharmaceutical company that manufactures and sells medicines and vaccines for different medical fields such as oncology, cardiology, immunology, and neurology. The company became central to the Covid-19 vaccination process, along with BioNTech SE (NASDAQ: BNTX). 

In Q1 2021, Pfizer Inc. (NYSE: PFE) generated $14.6 billion in revenues, showing 42% year-over-year growth. The EPS beat the market estimate of $0.77 and stood at $0.93. Pfizer Inc. (NYSE: PFE) sold vaccines worth $1.4 billion to the international market. The company expects the vaccine revenue to reach $26 billion in 2021. It has signed a $1.95 billion deal with the U.S. government for producing vaccines and has proved to be effective against the coronavirus variant, which is detected in India. This has certainly raised the PFE stock’s value, which has soared by 28.4% in the past year. Pfizer Inc. (NYSE: PFE) has announced a quarterly dividend of $0.39 per share and paid dividends worth $2.2 billion to shareholders in Q1.  

At the end of Q1 2021, 65 hedge funds tracked by Insider Monkey has stakes in Pfizer Inc. (NYSE: PFE), up from 63 in the previous quarter. The total value of these stakes is over $2 billion. 

ClearBridge Investments have mentioned Pfizer Inc. (NYSE: PFE) in their Q1 2021 investor letter with other stocks. Here is what the investment management firm has to say: 

“Our underweights in health care and staples contributed to relative performance during the period. As we continue to focus the portfolio on high-conviction ideas, we sold Pfizer in late 2020, in the health care sector.”